Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma
Autor: | Mark, Tomer M. *, Forsberg, Peter A., Rossi, Adriana C., Pearse, Roger N., Pekle, Karen A., Perry, Arthur, Boyer, Angelique, Tegnestam, Linda, Jayabalan, David, Coleman, Morton, Niesvizky, Ruben |
---|---|
Zdroj: | In Blood Advances 26 February 2019 3(4):603-611 |
Databáze: | ScienceDirect |
Externí odkaz: |